," said David Coffey, MD, Sylvester hematologic oncologist and researcher and the study's first author.
"We found a strong correlation between sustained MRD negativity and prolonged survival," said C. Ola Landgren, MD, Ph.D., chief of the Division of Myeloma at Sylvester and senior study author."In fact, patients who were treated with modern combination therapy and achieved and sustained MRD negativity for at least two years were highly likely to remain free from multiple myeloma 10 years later.
According to the American Cancer Society, almost 36,000 people will be diagnosed with multiple myeloma this year, and more than 170,000 patients are living with the disease. It is slightly more common in men than women, with age being a major risk factor. Compared to whites, Blacks have a two-fold higher risk of developing multiple myeloma and the average age of onset is about 10 years earlier.
Education Education Latest News, Education Education Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: medical_xpress - 🏆 101. / 51 Read more »